Exosens
EXENS.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | €224,515 | €207,213 | €186,887 | €166,819 |
| % Growth | 8.3% | 10.9% | 12% | – |
| Cost of Goods Sold | €85,403 | €160,179 | €134,955 | €114,108 |
| Gross Profit | €139,112 | €47,034 | €178,566 | €137,628 |
| % Margin | 62% | 22.7% | 95.5% | 82.5% |
| R&D Expenses | €7,522 | €0 | €7,350 | €900 |
| G&A Expenses | €70,418 | €57,011 | €56,631 | €82,857 |
| SG&A Expenses | €71,440 | €59,035 | €27,750 | €45,605 |
| Sales & Mktg Exp. | €1,022 | €2,024 | €1,297 | €1,648 |
| Other Operating Expenses | €13,433 | -€40,326 | -€18,046 | €50,455 |
| Operating Expenses | €92,395 | €18,709 | €17,054 | €96,960 |
| Operating Income | €46,717 | €49,174 | €27,726 | €41,016 |
| % Margin | 20.8% | 23.7% | 14.8% | 24.6% |
| Other Income/Exp. Net | -€8,327 | -€12,361 | -€22,739 | -€37,746 |
| Pre-Tax Income | €38,390 | €36,813 | €4,987 | €10,540 |
| Tax Expense | €10,481 | €8,977 | €914 | €205 |
| Net Income | €27,909 | €27,836 | -€630 | €8,424 |
| % Margin | 12.4% | 13.4% | -0.3% | 5% |
| EPS | 0.55 | 0.65 | -0.045 | 0.085 |
| % Growth | -15.4% | 1,544.4% | -153.1% | – |
| EPS Diluted | 0.55 | 0.65 | -0.045 | 0.085 |
| Weighted Avg Shares Out | 50,783 | 42,858 | 50,783 | 30,387 |
| Weighted Avg Shares Out Dil | 50,783 | 42,858 | 50,783 | 30,387 |
| Supplemental Information | – | – | – | – |
| Interest Income | €0 | €0 | €204 | €378 |
| Interest Expense | €6,839 | €8,341 | €19,498 | €24,670 |
| Depreciation & Amortization | €10,305 | €2,090 | €15,834 | €28,698 |
| EBITDA | €57,512 | €45,284 | €40,319 | €61,997 |
| % Margin | 25.6% | 21.9% | 21.6% | 37.2% |